Comparative Pharmacology
Head-to-head clinical analysis: NUTRESTORE versus STILPHOSTROL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NUTRESTORE versus STILPHOSTROL.
NUTRESTORE vs STILPHOSTROL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
NUTRESTORE is a medical food containing L-citrulline, L-ornithine, and other amino acids; its mechanism is not fully characterized but is hypothesized to enhance the urea cycle and reduce ammonia levels by providing substrates for ureagenesis, thereby improving nitrogen disposal in patients with urea cycle disorders or hyperammonemia.
Synthetic nonsteroidal estrogen; binds to estrogen receptors, inducing tumor regression in hormone-sensitive cancers.
One capsule (500 mg) orally three times daily.
0.5-1 mg/kg intravenously daily for 5 days, then 0.5 mg/kg intramuscularly weekly.
None Documented
None Documented
Terminal elimination half-life: 18-24 hours. Steady-state reached after 4-5 days. Clinical context: Allows once-daily dosing; prolonged in renal impairment.
Terminal elimination half-life: 50-60 hours (range 40-80 hr) due to enterohepatic recirculation; clinical context: steady-state achieved in ~10-14 days
Renal: 50-70% unchanged; biliary/fecal: 20-30% as metabolites; 5-10% in feces as parent drug.
Renal (primarily as glucuronide conjugates, 70-80%); fecal (biliary excretion of conjugates, 20-30%); <5% unchanged
Category C
Category C
Estrogen
Estrogen